U.S. market Closed. Opens in 17 hours 10 minutes

PNT | POINT Biopharma Global Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
Revenue226.58MN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A
Gross Profit226.58MN/AN/AN/A
Operating Expenses101.06M45.51M13.11M36.90K
Selling, General & Admin19.01M12.01M3.97M34.96K
Research & Development82.05M33.51M9.14M1.16K
Other Operating ExpensesN/AN/AN/AN/A
Operating Income125.52M-45.51M-13.11M-36.12K
Other Expenses / Income4.06M-84.99K-170.32K-780.00
Before Tax Income129.59M-45.60M-13.29M-36.90K
Income Tax Expenses31.29M305.66K87.88K-780.00
Net Income98.29M-45.90M-13.37M-36.90K
Interest Expenses-1.40M11.84K5.35KN/A
Basic Shares Outstanding94.60M73.85M38.88MN/A
Diluted Shares Outstanding96.03M73.85M38.88MN/A
EBITDA127.32M-45.51M-13.11M-780.00
EBITDA Margin56.19%0.00%0.00%0.00%
EBIT128.19M-45.58M-13.28M-37.68K
EBIT Margin56.58%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙